The present study provides contemporary data on the patterns of presentation, treatment, and outcome in the newly defined adult-type diffuse glioma group of IDH-mutant astrocytomas [7, 30] with a particular focus on astrocytoma, IDH-mutant, CNS WHO grade 4. Here, IDH2 is linked to astrocytoma (excluding glioblastoma).